SCHEMBL6170950

SCHEMBL6170950

Cc1csc(-c2onc(C)c2-c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 7/20 0.50
BRD2 P25440 2/20 0.50
TDO2 P48775 1/20 0.47
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PTGS1 P23219 2/20 0.38
PTGS2 P35354 2/20 0.38
NPC1 O15118 2/20 0.38
CASP3 P42574 2/20 0.38
RAB9A P51151 2/20 0.38
SENP7 Q9BQF6 2/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
POLB P06746 1/20 0.36
KCNA3 P22001 1/20 0.36
PTPN1 P18031 1/20 0.36
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8475587 0.88 BRD4 (0.46) BRD4BRD2TDO2ALDH1A1MAPT
SCHEMBL6514118 0.86 LMNA (0.37) BRD4BRD2TDO2ALDH1A1MAPT
SCHEMBL21105338 0.77 BRD4 (0.68) BRD4BRD2TDO2ALDH1A1MAPT
SCHEMBL6167859 0.75 NPC1 (0.38) BRD4BRD2ALDH1A1MAPTSMN1; SMN2
SCHEMBL72613 0.73 AR (0.43) SMN1; SMN2NPC1RAB9A
SCHEMBL6170416 0.70 PTGS1 (0.60) BRD4BRD2TDO2ALDH1A1MAPT
SCHEMBL27517533 0.70 BRD4 (0.49) BRD4BRD2TDO2MAPTSMN1; SMN2
SCHEMBL6511644 0.69 BRD4 (0.56) BRD4BRD2TDO2ALDH1A1MAPT
SCHEMBL6169678 0.69 PTGS2 (0.43) BRD4TDO2ALDH1A1MAPTPTGS1
3,5-Dimethyl-4-Phenylisoxazole SCHEMBL12134072 0.68 BRD4 (1.00) BRD4BRD2TDO2PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed